Margaret A Horn's Net Worth
$10.4 Million
Who is Margaret A Horn?
Margaret A Horn has an estimated net worth of $10.4 Million. This is based on reported shares across multiple companies, which include GENENCOR INTERNATIONAL INC, KOSAN BIOSCIENCES INC, Revolution Medicines, Inc., and SANGAMO THERAPEUTICS, INC.
SEC CIK
Margaret A Horn's CIK is 0001294192
Past Insider Trading and Trends
2023 was Margaret A Horn's most active year for acquiring shares with 11 total transactions. Margaret A Horn's most active month to acquire stocks was the month of February. 2023 was Margaret A Horn's most active year for disposing of shares, totalling 22 transactions. Margaret A Horn's most active month to dispose stocks was the month of February. 2005 saw Margaret A Horn paying a total of $1,081,500.00 for 150,000 shares, this is the most they've acquired in one year. In 2021 Margaret A Horn cashed out on 71,434 shares for a total of $1,967,200.19, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENENCOR INTERNATIONAL INC No price found
Sr. VP, General Counsel, Sect.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.28K |
$19.25 | -$43,947.75 |
0
|
Apr 20 - Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KOSAN BIOSCIENCES INC No price found
SVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revolution Medicines, Inc. (RVMD) Snapshot price: $41.84
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$27.22 | -$2,312,555.00 | 132.32K |
Oct 11
| |||
Form 4
| -3.17% | -4.33K |
$44.19 | -$191,366.53 | 132.32K |
Sep 16
| |||
Form 4
| -3.13% | -4.42K |
$37.39 | -$165,063.61 | 136.65K |
Jun 17
| |||
Form 4
| -2.05% | -2.91K |
$31.58 | -$92,033.44 | 139.55K |
Mar 18
| |||
Form 4
|
—
|
0
|
$19.06 | -$708,837.28 | 142.47K |
Mar 11 - Mar 12
| |||
Form 4
| +40.41% | 41K |
—
|
—
| 142.47K |
Mar 1
| |||
Form 4
| -2.87% | -2.99K |
$15.23 | -$190,257.09 | 101.47K |
Dec 15 - Dec 18
| |||
Form 4
|
—
|
0
|
$14.55 | -$104,550.00 | 104.46K |
Dec 6
| |||
Form 4
| +7.74% | 7.5K |
$0.54 | $4,050.00 | 104.46K |
Oct 25
| |||
Form 4
|
—
|
0
|
$19.02 | -$746,555.56 | 96.96K |
Oct 16
| |||
Form 4
| -2.53% | -2.51K |
$17.95 | -$218,673.10 | 96.96K |
Sep 15 - Sep 18
| |||
Form 4
|
—
|
0
|
$19.07 | -$299,558.00 | 99.47K |
Aug 31
| |||
Form 4
|
—
|
0
|
$17.31 | -$132,182.31 | 99.47K |
Aug 15
| |||
Form 4
| -2.07% | -2.10K |
$24.89 | -$52,320.88 | 99.47K |
Jun 20
| |||
Form 4
| -1.21% | -1.23K |
$21.78 | -$26,789.40 | 100.06K |
Mar 17
| |||
Form 4
| +65.26% | 40K |
—
|
—
| 101.29K |
Mar 1
| |||
Form 4
| -1.95% | -1.22K |
$22.94 | -$27,985.46 | 61.29K |
Dec 19
| |||
Form 4
| -100.00% | -17.77K |
$20.15 | -$358,069.01 |
0
|
Scheduled
|
Nov 7
| ||
Form 4
| -50.00% | -17.77K |
$20.41 | -$362,540.97 | 17.77K |
Scheduled
|
Oct 31
| ||
Form 4
| -33.33% | -17.77K |
$20.15 | -$357,968.34 | 35.53K |
Scheduled
|
Oct 26
| ||
Form 4
| -1.99% | -1.27K |
$19.04 | -$24,126.97 | 62.51K |
Sep 19
| |||
Form 4
| -1.76% | -1.15K |
$17.75 | -$20,323.18 | 63.78K |
Jun 17
| |||
Form 4
| -0.50% | -321.00 |
$18.61 | -$5,975.25 | 63.99K |
Mar 17
| |||
Form 4
| +152.11% | 38.8K |
—
|
—
| 64.31K |
Mar 1
| |||
Form 4
| -1.89% | -491.00 |
$24.41 | -$11,985.31 | 25.51K |
Dec 17
| |||
Form 4
| -1.81% | -479.00 |
$30.02 | -$14,379.58 | 26K |
Sep 17
| |||
Form 4
| -1.72% | -464.00 |
$34.13 | -$15,835.30 | 26.48K |
Jun 17
| |||
Form 4
| +133.95% | 15K |
—
|
—
| 26.2K |
Mar 4
| |||
Form 4
|
—
|
0
|
$29.87 | -$1,759,450.00 | 11.2K |
Scheduled
|
Feb 5
| ||
Form 4
| -56.77% | -70.00K |
$35.08 | -$2,455,490.04 | 53.3K |
Scheduled
|
Oct 1 - Oct 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +76.57% | 25K |
—
|
—
| 57.65K |
Jun 4
| |||
Form 4
| +74.13% | 13.9K |
—
|
—
| 32.65K |
Jun 1
| |||
Form 4
|
∞
| 18.75K |
—
|
—
| 18.75K |
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||